Metabolic syndrome in patients with depressive disorder--features of comorbidity
- PMID: 21448104
Metabolic syndrome in patients with depressive disorder--features of comorbidity
Abstract
Background: Depression is associated with increased physical morbidity and overall mortality. The results of a previous investigation on the relationship of the metabolic syndrome and its single components with coronary heart disease, cardiovascular disease (CVD), and all-cause mortality suggested that the metabolic syndrome is a marker of CVD risk, but not above and beyond the risk associated with its individual components. The aim of this article is to review literature regarding prevalence of metabolic syndrome in patients with depressive disorder, and association between metabolic syndrome and depression.
Content analysis of literature: Literature research included structured searches of Medline and other publications on the subject of metabolic syndrome, particularly prevalence of metabolic syndrome in patients with depressive disorder, and association between metabolic syndrome and depression.
Conclusion: Prevalence of the metabolic syndrome in patients with depression is high and varies among the analysed studies. Some investigations showed association between metabolic syndrome and depression. Further investigations are necessary in order to clarify the association between metabolic syndrome and depression.
Similar articles
-
No association of depression and anxiety with the metabolic syndrome: the Norwegian HUNT study.Acta Psychiatr Scand. 2009 Jul;120(1):14-22. doi: 10.1111/j.1600-0447.2008.01315.x. Epub 2009 Dec 22. Acta Psychiatr Scand. 2009. PMID: 19120047
-
Bipolar disorder and metabolic syndrome: comorbidity or side effects of treatment of bipolar disorder.Psychiatr Danub. 2010 Mar;22(1):75-8. Psychiatr Danub. 2010. PMID: 20305595 Review.
-
Associations between anxiety, depression, and the metabolic syndrome.Biol Psychiatry. 2007 Dec 1;62(11):1251-7. doi: 10.1016/j.biopsych.2007.01.012. Epub 2007 Jun 5. Biol Psychiatry. 2007. PMID: 17553465
-
Depression-anxiety relationships with chronic physical conditions: results from the World Mental Health Surveys.J Affect Disord. 2007 Nov;103(1-3):113-20. doi: 10.1016/j.jad.2007.01.015. Epub 2007 Feb 9. J Affect Disord. 2007. PMID: 17292480
-
Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables.Psychol Med. 2014 Jul;44(10):2017-28. doi: 10.1017/S0033291713002778. Epub 2013 Nov 21. Psychol Med. 2014. PMID: 24262678 Review.
Cited by
-
Role of glucocorticoid receptor phosphorylation-mediated synaptic plasticity in anxiogenic and depressive behaviors induced by monosodium glutamate.Naunyn Schmiedebergs Arch Pharmacol. 2021 Jan;394(1):151-164. doi: 10.1007/s00210-020-01845-x. Epub 2020 May 22. Naunyn Schmiedebergs Arch Pharmacol. 2021. PMID: 32444989
-
Depression and Metabolic Syndrome: A Narrative Review.Cureus. 2022 Feb 12;14(2):e22153. doi: 10.7759/cureus.22153. eCollection 2022 Feb. Cureus. 2022. PMID: 35308733 Free PMC article. Review.
-
Analysis of Antidepressant Activity of Huang-Lian Jie-Du Decoction Through Network Pharmacology and Metabolomics.Front Pharmacol. 2021 Mar 4;12:619288. doi: 10.3389/fphar.2021.619288. eCollection 2021. Front Pharmacol. 2021. PMID: 33746756 Free PMC article.
-
Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review.Curr Neuropharmacol. 2015;13(5):636-55. doi: 10.2174/1570159x13666150630175044. Curr Neuropharmacol. 2015. PMID: 26467412 Free PMC article. Review.
-
Depression, anxiety disorders, and metabolic syndrome in a population at risk for type 2 diabetes mellitus.Brain Behav. 2015 Mar;5(3):e00306. doi: 10.1002/brb3.306. Epub 2015 Jan 21. Brain Behav. 2015. PMID: 25642391 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials